Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “SION”

1,496 pharma patents match "SION" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,496
Index total 30,257
Page 46 / 63

Quick answer

This filtered view shows 1,496 pharmaceutical patents matching "SION" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,496 results for “SION” · 30,257 patents in full index Clear search

  1. US 8470799

    Compositions and methods for inhibiting expression of the HAMP gene

    Alnylam Pharmaceuticals, Inc. · Granted Jun 25, 2013 · Expires Jun 20, 2033

    granted

  2. US 8465737

    Three-dimensional structure of complement receptor type 2 and uses thereof

    The Regents of the University of Colorado · Granted Jun 18, 2013 · Expires Jun 13, 2033

    granted

  3. US 8460675

    Viral chemokine-antigen fusion proteins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted

  4. US 8460864

    Methods for identifying compounds that modulate untranslated region-dependent gene expression and methods of using same

    PTC THERAPEUTICS, INC. · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted

  5. US 8445044

    Food thickening agent, method for producing food thickening agent

    Kent Precision Foods Group, Inc. · Granted May 21, 2013 · Expires May 16, 2033

    granted

  6. US 8445434

    IGF-1 fusion polypeptides and therapeutic uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted May 21, 2013 · Expires May 16, 2033

    granted

  7. US 8445251

    Rationally-designed single-chain meganucleases with non-palindromic recognition sequences

    Precision BioSciences, Inc. · Granted May 21, 2013 · Expires May 16, 2033

    granted

  8. US 8445254

    Regulated expression of antigen and/or regulated attentuation to enhance vaccine immunogenicity and/or safety

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted May 21, 2013 · Expires May 16, 2033

    granted

  9. US 8440411

    Differential gene expression in physiological and pathological angiogenesis

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted May 14, 2013 · Expires May 9, 2033

    granted

  10. US 8431532

    FZD8 extracellular domains and FZD8 extracellular domain fusion molecules and treatments using same

    Five Prime Therapeutics, Inc. · Granted Apr 30, 2013 · Expires Apr 25, 2033

    granted

  11. US 8426385

    Pharmaceutical composition comprising cyclodextrin paclitaxel inclusion and preparation method thereof

    Hainan Hdeton Science and Technology Co., Ltd. · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  12. US 8420619

    Rescue of photoreceptors by intravitreal administration of an expression vector encoding a therapeutic protein

    Ceregene, Inc. · Granted Apr 16, 2013 · Expires Apr 11, 2033

    granted

  13. US 8415384

    Reducing myocardial reperfusion injury by the combination therapy of protein kinase A activation and B1-adrenergic receptor blockade

    The Board of Regents of the University of Texas System · Granted Apr 9, 2013 · Expires Apr 4, 2033

    granted

  14. US 8410261

    Compositions and methods for inhibiting expression of a gene from the JC virus

    Alnylam Pharmaceuticals, Inc. · Granted Apr 2, 2013 · Expires Mar 28, 2033

    granted

  15. US 8410121

    Methods of treating pulmonary hypertension

    LEXICON PHARMACEUTICALS, INC. · Granted Apr 2, 2013 · Expires Mar 28, 2033

    granted

  16. US 8389502

    Stabilized steroid composition and method for its preparation

    Precision Dermatology, Inc. · Granted Mar 5, 2013 · Expires Feb 28, 2033

    granted

  17. US 8388643

    Bioabsorbable polymeric implants and a method of using the same to create occlusions

    The Regents of the University of California · Granted Mar 5, 2013 · Expires Feb 28, 2033

    granted

  18. US 8383102

    Fusion of peptidoglycan hydrolase enzymes to a protein transduction domain allows eradication of both extracellular and intracellular gram positive pathogens

    The United States of America, as represented by the Secretary of Agriculture · Granted Feb 26, 2013 · Expires Feb 21, 2033

    granted

  19. US 8378084

    Fusion molecule based on novel TAA variant

    The Regents of the University of California · Granted Feb 19, 2013 · Expires Feb 14, 2033

    granted

  20. US 8365314

    Coated elastomeric article and method for making a coated elastomeric article

    Precision Components, Inc. · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted

  21. US 8367734

    Stable epinephrine suspension formulation with high inhalation delivery efficiency

    Amphastar Pharmaceuticals, Inc. · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted

  22. US 8361982

    Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell

    The Regents of the University of California · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted

  23. US 8354390

    Compositions and methods for inhibiting expression of a gene from the ebola virus

    The United States of America as represented by the Secretary of the Army · Granted Jan 15, 2013 · Expires Jan 10, 2033

    granted

  24. US 8349371

    Method for anti-oxidation, inhibiting activity and/or expression of matrix metalloproteinase, and/or inhibiting phosphorylation of mitogen-activated protein kinase using neonauclea reticulata leaf extracts

    China Medical University · Granted Jan 8, 2013 · Expires Jan 3, 2033

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.